All news

Avalo Therapeutics to Attend Two Investor Conferences

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Avalo Therapeutics (AVTX) management is scheduled to participate in two investor conferences. They will present at the Guggenheim Healthcare Innovation Conference on November 9, 2026, and the Stifel 2026 Healthcare Conference on November 10, 2026. Webcasts of these fireside chats will be available on the company's investor website for at least 30 days.

Read original source

AVTX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.